Effect of awake prone position on diaphragmatic thickening fraction in patients assisted by noninvasive ventilation for hypoxemic acute respiratory failure related to novel coronavirus disease

Table 1 Patients’ characteristics at enrollment

Patients	Gender	Age	Comorbidities	BMI (kg/m²)	PBW (kg)	NIV before study enrollment (days)	Sedation	FiO₂ (%)	PS (cmH₂O)	PEEP (cmH₂O)
1	F	68	Arterial hypertension	31.2	58.3	1		70	10	10
2	M	40	Other medical disease	26	70.6	3	Dexmedetomidine	60	10	10
3	M	54	–	26	66.0	2	Dexmedetomidine	40	10	8
4	F	60	–	27.7	61	2		50	10	10
5	M	71	History of cancer	24.7	75.1	4		55	6	10
6	F	57	Arterial hypertension	25.7	61.0	2		50	9	12
7	M	57	Arterial hypertension, dyslipidemia	38.5	80.0	1		50	5	12
8	M	46	–	24.7	83.5	1	Dexmedetomidine	45	5	8
9	M	79	Arterial hypertension, diabetes	31.2	64.9	2	Dexmedetomidine	45	5	9
10	M	75	Arterial hypertension	27.1	71.0	2	Dexmedetomidine	60	6	10
11	F	53	Other medical disease	29.5	61.5	1	Dexmedetomidine	100	8	8
12	M	73	Arterial hypertension, chronic kidney disease	31.9	65.0	2	Dexmedetomidine	50	6	10
13	F	71	Arterial hypertension, dyslipidemia, cardiovascular disease	44.9	51.9	2		60	12	10
14	M	62	Arterial hypertension, dyslipidemia, cardiovascular disease	27	63	1	Dexmedetomidine	65	5	8
15	M	51	Arterial hypertension, dyslipidemia	32.7	61.5	1		50	6	8
16	M	77	–	26.1	68.9	1	Dexmedetomidine	75	10	10
17	M	68	–	28	70	1	Dexmedetomidine + Morphine	50	10	10
18	M	68	–	31	72	1	Dexmedetomidine + Morphine	70	10	12
19	M	77	Arterial hypertension, cardiovascular disease, diabetes	29	69	1	Dexmedetomidine + Morphine	75	10	10
20	M	49	Arterial hypertension	28	70	1		40	8	10
Overall	16M/4F	65 (54–72)		28 (26–31)	68 (62–71)	2 (1–2)		53 (50–66)	9 (6–10)	10 (9–10)

BMI, body mass index; PBW, predicted body weight, NIV, noninvasive ventilation; FiO₂, inspired oxygen fraction; PS, pressure support over PEEP; PEEP, positive end-expiratory pressure

ISSN: 1364-8535